About Project Farma
Project Farma is a company based in Bethesda (United States) founded in 2013 was acquired by PerkinElmer in March 2025. Project Farma offers products and services including Facility Builds, Tech Transfers, Validation Services, and Engineering and Automation. Project Farma operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
- Headquarter Bethesda, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Precision Medicine Group
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Project Farma
Project Farma offers a comprehensive portfolio of products and services, including Facility Builds, Tech Transfers, Validation Services, and Engineering and Automation.
Service for constructing GMP-compliant biomanufacturing facilities
Assistance in transferring biomanufacturing technologies to new sites
Ensuring compliance and validation of biomanufacturing processes
Design and implementation of automation for biomanufacturing operations
People of Project Farma
Unlock access to complete
Funding Insights of Project Farma
Detailed funding history for Project Farma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Project Farma
Project Farma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Precision Medicine Group and PerkinElmer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical instruments and supplies are manufactured and provided for healthcare.
|
Locked | Locked | Locked | |
|
Provider of clinical research, development, and commercialization services for life sciences
|
Locked | Locked | Locked |
Investor details for Project Farma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Project Farma
Investment portfolio details for Project Farma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Project Farma
Detailed financials for Project Farma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Project Farma Comparisons
Peer comparison for Project Farma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Project Farma
Project Farma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
|
| Locked | Locked | Locked |
Strategic consulting services are provided to life sciences companies.
|
Detailed competitors of Project Farma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Project Farma
Complete news archive for Project Farma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Project Farma
Project Farma was founded in 2013.
Project Farma is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.
Anshul Mangal is the current CEO of Project Farma.
Project Farma was established in 2013 in Bethesda, United States. Services encompassing consulting, quality assurance, regulatory compliance, and marketing are delivered to the biopharmaceutical sector. Operations center on assisting companies with specialized support in these domains. The firm operates primarily from its U.S. base, addressing needs in drug development and commercialization processes. Key leadership includes Anshul Mangal as CEO.
Project Farma's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Project Farma offers Facility Builds, Tech Transfers, Validation Services, and Engineering and Automation.
Project Farma has 2 investors. Key investors include Precision Medicine Group, and PerkinElmer.